309 related articles for article (PubMed ID: 29429153)
21. Green tea catechins potentiate the effect of antibiotics and modulate adherence and gene expression in Porphyromonas gingivalis.
Fournier-Larente J; Morin MP; Grenier D
Arch Oral Biol; 2016 May; 65():35-43. PubMed ID: 26849416
[TBL] [Abstract][Full Text] [Related]
22. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
Singh BN; Shankar S; Srivastava RK
Biochem Pharmacol; 2011 Dec; 82(12):1807-21. PubMed ID: 21827739
[TBL] [Abstract][Full Text] [Related]
23. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
[TBL] [Abstract][Full Text] [Related]
24. Novel mechanisms of anticancer activities of green tea component epigallocatechin- 3-gallate.
Zhang L; Wei Y; Zhang J
Anticancer Agents Med Chem; 2014; 14(6):779-86. PubMed ID: 24851882
[TBL] [Abstract][Full Text] [Related]
25. (-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells.
Namiki K; Wongsirisin P; Yokoyama S; Sato M; Rawangkan A; Sakai R; Iida K; Suganuma M
Sci Rep; 2020 Feb; 10(1):2444. PubMed ID: 32051483
[TBL] [Abstract][Full Text] [Related]
26. Cancer inhibition by green tea.
Fujiki H; Suganuma M; Okabe S; Sueoka N; Komori A; Sueoka E; Kozu T; Tada Y; Suga K; Imai K; Nakachi K
Mutat Res; 1998 Jun; 402(1-2):307-10. PubMed ID: 9675322
[TBL] [Abstract][Full Text] [Related]
27. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.
Almatroodi SA; Almatroudi A; Khan AA; Alhumaydhi FA; Alsahli MA; Rahmani AH
Molecules; 2020 Jul; 25(14):. PubMed ID: 32660101
[TBL] [Abstract][Full Text] [Related]
28. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
Nagle DG; Ferreira D; Zhou YD
Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
[TBL] [Abstract][Full Text] [Related]
29. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
30. Green tea: Health benefits as cancer preventive for humans.
Fujiki H
Chem Rec; 2005; 5(3):119-32. PubMed ID: 15889414
[TBL] [Abstract][Full Text] [Related]
31. Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway.
Rahmani AH; Al Shabrmi FM; Allemailem KS; Aly SM; Khan MA
Biomed Res Int; 2015; 2015():925640. PubMed ID: 25977926
[TBL] [Abstract][Full Text] [Related]
32. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.
Negri A; Naponelli V; Rizzi F; Bettuzzi S
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563268
[TBL] [Abstract][Full Text] [Related]
33. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.
Chen D; Wan SB; Yang H; Yuan J; Chan TH; Dou QP
Adv Clin Chem; 2011; 53():155-77. PubMed ID: 21404918
[TBL] [Abstract][Full Text] [Related]
34. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
[TBL] [Abstract][Full Text] [Related]
35. Epigallocatechin gallate from green tea exhibits potent anticancer effects in A-549 non-small lung cancer cells by inducing apoptosis, cell cycle arrest and inhibition of cell migration.
Huang J; Chen S; Shi Y; Li CH; Wang XJ; Li FJ; Wang CH; Meng QH; Zhong JN; Liu M; Wang ZM
J BUON; 2017; 22(6):1422-1427. PubMed ID: 29332333
[TBL] [Abstract][Full Text] [Related]
36. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
[TBL] [Abstract][Full Text] [Related]
37. (‑)‑Epigallocatechin‑3‑gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway.
Sun X; Song J; Li E; Geng H; Li Y; Yu D; Zhong C
Oncol Rep; 2019 Jul; 42(1):425-435. PubMed ID: 31180522
[TBL] [Abstract][Full Text] [Related]
38. Mechanism-based inhibition of cancer metastasis with (-)-epigallocatechin gallate.
Takahashi A; Watanabe T; Mondal A; Suzuki K; Kurusu-Kanno M; Li Z; Yamazaki T; Fujiki H; Suganuma M
Biochem Biophys Res Commun; 2014 Jan; 443(1):1-6. PubMed ID: 24269590
[TBL] [Abstract][Full Text] [Related]
39. Green tea and its catechins inhibit breast cancer xenografts.
Sartippour MR; Heber D; Ma J; Lu Q; Go VL; Nguyen M
Nutr Cancer; 2001; 40(2):149-56. PubMed ID: 11962250
[TBL] [Abstract][Full Text] [Related]
40. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
Liu X; Zhang DY; Zhang W; Zhao X; Yuan C; Ye F
Nutr Cancer; 2011; 63(3):466-75. PubMed ID: 21391127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
